Home > Drug Search >
  • company_query: Alloksys Life Sciences
  •   > 
Drug Filter
Category:
chemistry (15) biology (26)
Status:
Approved (3) NDA Filing (1) Phase Ⅲ (5) Phase Ⅱ (14) Phase Ⅰ (18)
Clinical Stage:
Pending (8) Active (22) Discontinued (8)
Bio-Type:
Gene therapy (2) Cell therapy (1) Vaccine (14) Recombinant enzyme (1) Other recombinant protein (1) Whole antibody (2) ADC (2) Fusion protein (1)
Indication:
Acute bacterial skin and skin structure infections (ABSSSI) (1) Acute lymphoblastic leukaemia (ALL) (1) Amyotrophic lateral sclerosis (ALS) (1) Atherosclerosis (1) Breast cancer (3) Eye disorders (1) HCV infection (1) HIV infection (1) Hyperlipidemia (1) Hypertension (1) Melanoma (2) Multiple sclerosis (MS) (2) Non small cell lung cancer (NSCLC) (4) Ovarian cancer (2) Pancreatic cancer (2) Psoriasis (1) Respiratory tract infection (1) Rheumatoid arthritis (RA) (2) Solid tumours (2) Rotavirus infection (1) Acute intermittent porphyria (1) Retinal dystrophies (1) Carotid stenosis (1) Metamfetamine abuse (1) Colorectal cancer (2) Ankylosing Spondylitis (AS) (1) Venezuelan equine encephalitis virus infection (1) Age-related macular degeneration (AMD) (1) Pain (1) Otitis Media (1) Sarcoma (3) B-cell lymphoma (2) Diagnostic agents (2) Malaria (1) Renal carcinoma (1) Hypertrophic cardiomyopathy (1) Cardiomyopathy (1) Viral hemorrhagic fever (1) Alcoholism (1) Glioblastoma (1) Mesothelioma (1) Dengue fever (2) Bacterial infection (1) Liver cancer (1) Choroidal neovascularisation (1) Scleroderma (2)
Country:
Aprv. Year:
2016 (1) 2017 (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 3 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top